CSS
RMD icon

Cubist Systematic Strategies’s ResMed RMD Stock Holding History

Cubist Systematic Strategies’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-600
Closed -$155K – 3471
2025
Q2 		$155K Buy
+600
New +$143K ﹤0.01% 2650
2024
Q4 		– Sell
-3,800
Closed -$928K – 3477
2024
Q3 		$928K Hold
3,800
– – 0.01% 1880
2024
Q2 		$727K Sell
3,800
-33,800
-90% -$6.86M 0.01% 1930
2024
Q1 		$7.45M Sell
37,600
-3,500
-9% -$641K 0.04% 700
2023
Q4 		$7.07M Buy
41,100
+7,700
+23% +$1.18M 0.05% 657
2023
Q3 		$4.94M Buy
+33,400
New +$6.04M 0.04% 762

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Cubist Systematic Strategies's RMD Position: Q4 2023 in Review

Cubist Systematic Strategies sold out of ResMed (RMD) in Q4 2023, closing a stake of 11,486 shares — an estimated $1.76M sold.

Cubist Systematic Strategies first reported a position in RMD in Q2 2014 and held it in 32 quarters. The position peaked at $49.2M in Q2 2023. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

  • Cubist Systematic Strategies reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 11,486 ResMed shares in Q4 2023, an estimated $1.76M.
  • Cubist Systematic Strategies first reported a position in ResMed in Q2 2014 and held it in 32 quarters.
  • Cubist Systematic Strategies's ResMed position peaked at $49.2M in Q2 2023.
  • 687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.